{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:59:21Z","timestamp":1780372761576,"version":"3.54.1"},"reference-count":31,"publisher":"The Journal of Rheumatology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Cardiovascular (CV) morbidity and mortality are increased in axial spondyloarthritis (axSpA).<\/jats:p><jats:p>We conducted a cross-sectional study evaluating the 10-year atherosclerotic cardiovascular disease (ASCVD) risk in axSpA compared to the general US population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We included 211 adults, 40\u201375 years old with ankylosing spondylitis (AS) or nonradiographic axSpA from 2 sites, who had available data on comorbidities, medication use, blood pressure measures, and laboratory cholesterol values. General population comparators from the 2009\u20132014 National Health and Examination Survey (NHANES) cycles were matched 4:1 to subjects, on age, sex, and race. We estimated the prevalence ratio for a 10-year ASCVD risk score \u2265 7.5% comparing axSpA and matched NHANES comparators using conditional Poisson regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Overall, subjects were 53.9 \u00b1 11.2 years old, 69% were male, and 74% were White. The mean 10-year ASCVD risk score was 6.7 \u00b1 6.9% for those with axSpA, and 9.0 \u00b1 10.5% for NHANES comparators. Compared to those with axSpA, the prevalence of current smoking and diabetes was higher among NHANES comparators. The estimated prevalence ratio for a 10-year ASCVD risk score \u2265 7.5% comparing those with axSpA and their age-, sex-, and race-matched comparators was 0.96 (95% CI 0.74\u20131.24).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>The prevalence of a 10-year ASCVD risk score \u2265 7.5% was not significantly different comparing axSpA patients and those drawn from the general population who were similar in terms of age, sex, and race. Future studies should focus on improved CV risk prediction in axSpA, because underestimation by a general population risk score may potentially explain these results.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.200188","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T16:25:38Z","timestamp":1593620738000},"page":"361-366","source":"Crossref","is-referenced-by-count":10,"title":["Cardiovascular Risk Scores in Axial Spondyloarthritis Versus the General Population: A Cross-sectional Study"],"prefix":"10.3899","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8104-2450","authenticated-orcid":false,"given":"Jean W.","family":"Liew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Reveille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Naovarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Heckbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne S.","family":"Gensler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"2022070101451360000_48.3.361.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151191"},{"key":"2022070101451360000_48.3.361.2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2470"},{"key":"2022070101451360000_48.3.361.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213317"},{"key":"2022070101451360000_48.3.361.4","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20408"},{"key":"2022070101451360000_48.3.361.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.02.008"},{"key":"2022070101451360000_48.3.361.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-013-2927-5"},{"key":"2022070101451360000_48.3.361.7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181c10773"},{"key":"2022070101451360000_48.3.361.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken198"},{"key":"2022070101451360000_48.3.361.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei145"},{"key":"2022070101451360000_48.3.361.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206773"},{"key":"2022070101451360000_48.3.361.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.002"},{"key":"2022070101451360000_48.3.361.12","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022070101451360000_48.3.361.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211253"},{"key":"2022070101451360000_48.3.361.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208174"},{"key":"2022070101451360000_48.3.361.15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2018","journal-title":"N Engl J Med"},{"key":"2022070101451360000_48.3.361.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215707"},{"key":"2022070101451360000_48.3.361.17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/art.21444","article-title":"Risk factors for functional limitations in patients with long-standing ankylosing spondylitis","volume":"53","author":"Ward","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2022070101451360000_48.3.361.18","first-page":"2935","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"25","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"2022070101451360000_48.3.361.19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022070101451360000_48.3.361.20","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-015-0532-3"},{"key":"2022070101451360000_48.3.361.21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170379"},{"key":"2022070101451360000_48.3.361.22","doi-asserted-by":"crossref","first-page":"2476239","DOI":"10.1155\/2018\/2476239","article-title":"Red cell distribution width is positively correlated with atherosclerotic cardiovascular disease 10-year risk score, age, and CRP in spondyloarthritis with axial or peripheral disease","volume":"2018","author":"Ahmad","year":"2018","journal-title":"Int J Rheumatol"},{"key":"2022070101451360000_48.3.361.23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00296-016-3614-0","article-title":"Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study","volume":"37","author":"Nissen","year":"2017","journal-title":"Rheumatol Int"},{"key":"2022070101451360000_48.3.361.24","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141018"},{"key":"2022070101451360000_48.3.361.25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1847894","article-title":"Relative risk chart score for the assessment of the cardiovascular risk in young patients with ankylosing spondylitis","volume":"2018","author":"Rueda-Gotor","year":"2018","journal-title":"Int J Rheumatol."},{"key":"2022070101451360000_48.3.361.26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170025"},{"key":"2022070101451360000_48.3.361.27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jbspin.2017.07.002","article-title":"Is the SCORE chart underestimating the real cardiovascular (CV) risk of patients with psoriatic arthritis? Prevalence of subclinical CV disease detected by carotid ultrasound","volume":"85","author":"Martinez-Vidal","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2022070101451360000_48.3.361.28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181223"},{"key":"2022070101451360000_48.3.361.29","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/acr.22536","article-title":"Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study","volume":"67","author":"Ernste","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2022070101451360000_48.3.361.30","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"2022070101451360000_48.3.361.31","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170630"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.200188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T08:48:47Z","timestamp":1656665327000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.200188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,1]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.3899\/jrheum.200188"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.200188","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}